BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3958270)

  • 21. Psoralens and UV-A and UV-B twice weekly for the treatment of psoriasis.
    Diette KM; Momtaz-T K; Stern RS; Arndt KA; Parrish JA
    Arch Dermatol; 1984 Sep; 120(9):1169-73. PubMed ID: 6476854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen.
    Berg M; Ros AM
    Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo.
    McNeely W; Goa KL
    Drugs; 1998 Oct; 56(4):667-90. PubMed ID: 9806110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA).
    Pariser DM; Wyles RJ
    J Am Acad Dermatol; 1980 Sep; 3(3):248-50. PubMed ID: 7451691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial photochemotherapy of psoriasis with orally administered 8-methoxypsoralen and longwave ultraviolet light (PUVA).
    Siddiqui AH; Cormane RH
    Br J Dermatol; 1979 Mar; 100(3):247-50. PubMed ID: 435382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
    Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
    Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
    Koulu LM; Jansén CT
    J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():11-21. PubMed ID: 22512676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The occurrence of vitiligo after psoralens and ultraviolet a therapy.
    Todes-Taylor N; Abel EA; Cox AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):526-32. PubMed ID: 6630615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal lymphocyte function following long-term PUVA therapy for psoriasis.
    Morison WL; Wimberly J; Parrish JA; Bloch KJ
    Br J Dermatol; 1983 Apr; 108(4):445-50. PubMed ID: 6838768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen.
    Lowe NJ; Weingarten D; Bourget T; Moy LS
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):754-60. PubMed ID: 3711379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA.
    Takashima A; Yamamoto K; Kimura S; Takakuwa Y; Mizuno N
    Br J Dermatol; 1991 Jan; 124(1):37-42. PubMed ID: 1993143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis.
    Boer J; Hermans J; Schothorst AA; Suurmond D
    Arch Dermatol; 1984 Jan; 120(1):52-7. PubMed ID: 6691715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP).
    Ravenscroft J; Goulden V; Wilkinson M
    J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S218-9. PubMed ID: 11712064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
    Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of psoriasis with polyethylene sheet bath PUVA.
    Streit V; Wiedow O; Christophers E
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):208-10. PubMed ID: 8708022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
    Stern RS; Morison WL; Thibodeau LA; Kleinerman RA; Parrish JA; Geer DE; Fitzpatrick TB
    Arch Dermatol; 1979 Nov; 115(11):1320-4. PubMed ID: 389166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis.
    Collins P; Rogers S
    Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.